{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:44:53Z","timestamp":1788965093424,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41375-026-02946-x","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:01:11Z","timestamp":1776160871000},"page":"1240-1246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pre-diagnostic clonal hematopoiesis of indeterminate potential among patients with a primary cancer and risk of second cancers"],"prefix":"10.1038","volume":"40","author":[{"given":"Xinyuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Olov","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1304-0784","authenticated-orcid":false,"given":"Erik","family":"Boberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin E.","family":"Smedby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1674-3792","authenticated-orcid":false,"given":"Hui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4687-100X","authenticated-orcid":false,"given":"Qianwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"2946_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2946_CR2","first-page":"409","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72:409\u201336.","journal-title":"CA Cancer J Clin"},{"key":"2946_CR3","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1634\/theoncologist.2011-0214","volume":"16","author":"AM VanderWalde","year":"2011","unstructured":"VanderWalde AM, Hurria A. Second malignancies among elderly survivors of cancer. Oncologist. 2011;16:1572\u201381.","journal-title":"Oncologist"},{"key":"2946_CR4","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/S1470-2045(16)30573-3","volume":"18","author":"DK Mayer","year":"2017","unstructured":"Mayer DK, Nasso SF, Earp JA. Defining cancer survivors, their needs, and perspectives on survivorship health care in the USA. Lancet Oncol. 2017;18:e11\u20138.","journal-title":"Lancet Oncol"},{"key":"2946_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrclinonc.2013.41","volume":"10","author":"LB Travis","year":"2013","unstructured":"Travis LB, Demark Wahnefried W, Allan JM, Wood ME, Ng AK. Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol. 2013;10:289\u2013301.","journal-title":"Nat Rev Clin Oncol"},{"key":"2946_CR6","doi-asserted-by":"crossref","unstructured":"Morton LM, Onel K, Curtis RE, Hungate EA, Armstrong GT. The rising incidence of second cancers: patterns of occurrence and identification of risk factors for children and adults. American Society of Clinical Oncology educational book American Society of Clinical Oncology Annual Meeting. 2014:e57\u201367.","DOI":"10.14694\/EdBook_AM.2014.34.e57"},{"key":"2946_CR7","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/jnci\/djs351","volume":"104","author":"AK Win","year":"2012","unstructured":"Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, et al. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst. 2012;104:1363\u201372.","journal-title":"J Natl Cancer Inst"},{"key":"2946_CR8","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/cncr.27842","volume":"119","author":"SM Domchek","year":"2013","unstructured":"Domchek SM, Jhaveri K, Patil S, Stopfer JE, Hudis C, Powers J, et al. Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer. Cancer. 2013;119:1344\u20138.","journal-title":"Cancer"},{"key":"2946_CR9","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese G, K\u00e4hler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371:2477\u201387.","journal-title":"N Engl J Med"},{"key":"2946_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","volume":"126","author":"DP Steensma","year":"2015","unstructured":"Steensma DP, Bejar R, Jaiswal S, Lindsley RC, Sekeres MA, Hasserjian RP, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015;126:9\u201316.","journal-title":"Blood"},{"key":"2946_CR11","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.stem.2022.05.006","volume":"29","author":"MA Florez","year":"2022","unstructured":"Florez MA, Tran BT, Wathan TK, DeGregori J, Pietras EM, King KY. Clonal hematopoiesis: mutation-specific adaptation to environmental change. cell stem cell. 2022;29:882\u2013904.","journal-title":"cell stem cell"},{"key":"2946_CR12","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371:2488\u201398.","journal-title":"N Engl J Med"},{"key":"2946_CR13","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","volume":"52","author":"KL Bolton","year":"2020","unstructured":"Bolton KL, Ptashkin RN, Gao T, Braunstein L, Devlin SM, Kelly D, et al. Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nat Genet. 2020;52:1219\u201326.","journal-title":"Nat Genet"},{"key":"2946_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/jnci\/djz157","volume":"112","author":"EA Comen","year":"2020","unstructured":"Comen EA, Bowman RL, Selenica P, Kleppe M, Farnoud NR, Pareja F, et al. Evaluating clonal hematopoiesis in tumor-infiltrating leukocytes in breast cancer and secondary hematologic malignancies. J Natl Cancer Inst. 2020;112:107\u201310.","journal-title":"J Natl Cancer Inst"},{"key":"2946_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S1470-2045(16)30627-1","volume":"18","author":"NK Gillis","year":"2017","unstructured":"Gillis NK, Ball M, Zhang Q, Ma Z, Zhao Y, Yoder SJ, et al. Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study. Lancet Oncol. 2017;18:112\u201321.","journal-title":"Lancet Oncol"},{"key":"2946_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1470-2045(16)30626-X","volume":"18","author":"K Takahashi","year":"2017","unstructured":"Takahashi K, Wang F, Kantarjian H, Doss D, Khanna K, Thompson E, et al. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study. Lancet Oncol. 2017;18:100\u201311.","journal-title":"Lancet Oncol"},{"key":"2946_CR17","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12:e1001779.","journal-title":"PLoS Med"},{"key":"2946_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203\u20139.","journal-title":"Nature"},{"key":"2946_CR19","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1002\/ajh.70028","volume":"100","author":"X Liu","year":"2025","unstructured":"Liu X, Adami HO, W\u00e4sterlid T, Xue H, Feychting M, Smedby KE, et al. Association of pre-diagnostic clonal hematopoiesis of indeterminate potential with prognosis among patients with cancer. Am J Hematol. 2025;100:1993\u20132003.","journal-title":"Am J Hematol"},{"key":"2946_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102753","volume":"74","author":"Q Liu","year":"2024","unstructured":"Liu Q, Smedby KE, Xue H, W\u00e4sterlid T, Li J, Fang F, et al. Clonal hematopoiesis of indeterminate potential and the risk of pulmonary embolism: an observational study. EClinicalMedicine. 2024;74:102753.","journal-title":"EClinicalMedicine"},{"key":"2946_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/joim.20001","volume":"296","author":"X Liu","year":"2024","unstructured":"Liu X, Xue H, Wirdefeldt K, Song H, Smedby K, Fang F, et al. Clonal hematopoiesis of indeterminate potential and risk of neurodegenerative diseases. J Intern Med. 2024;296:327\u201335.","journal-title":"J Intern Med"},{"key":"2946_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/joim.20092","volume":"297","author":"Q Liu","year":"2025","unstructured":"Liu Q, W\u00e4sterlid T, Smedby KE, Xue H, Boberg E, Fang F, et al. Clonal hematopoiesis of indeterminate potential and risk of immune thrombocytopenia. J Intern Med. 2025;297:672\u201382.","journal-title":"J Intern Med"},{"key":"2946_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04077-z","volume":"23","author":"X Zhang","year":"2025","unstructured":"Zhang X, Wang Y, Xue H, Zhao Y, Liu M, Wei H, et al. Clonal hematopoiesis of indeterminate potential and risk of autoimmune thyroid disease. BMC Med. 2025;23:237.","journal-title":"BMC Med"},{"key":"2946_CR24","unstructured":"David B, Takuto S, Kristian C, Gad G, Chip S, Lee L. Calling Somatic SNVs and Indels with Mutect2. bioRxiv. 2019:861054."},{"key":"2946_CR25","first-page":"2214","volume":"141","author":"C Vlasschaert","year":"2023","unstructured":"Vlasschaert C, Mack T, Heimlich JB, Niroula A, Uddin MM, Weinstock J, et al. A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data sets. Blood. 2023;141:2214\u201323.","journal-title":"Blood"},{"key":"2946_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jmoldx.2021.10.013","volume":"24","author":"CA Miller","year":"2022","unstructured":"Miller CA, Walker JR, Jensen TL, Hooper WF, Fulton RS, Painter JS, et al. Failure to detect mutations in U2AF1 due to changes in the GRCh38 reference sequence. J Mol Diagn. 2022;24:219\u201323.","journal-title":"J Mol Diagn"},{"key":"2946_CR27","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164.","journal-title":"Nucleic Acids Res"},{"key":"2946_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","volume":"625","author":"S Chen","year":"2024","unstructured":"Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature. 2024;625:92\u2013100.","journal-title":"Nature"},{"key":"2946_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000521288","volume":"91","author":"ME Charlson","year":"2022","unstructured":"Charlson ME, Carrozzino D, Guidi J, Patierno C. Charlson Comorbidity Index: a critical review of clinimetric properties. Psychother Psychosom. 2022;91:8\u201335.","journal-title":"Psychother Psychosom"},{"key":"2946_CR30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167:268\u201374.","journal-title":"Ann Intern Med"},{"key":"2946_CR31","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1200\/JCO.2016.71.6712","volume":"35","author":"CJ Gibson","year":"2017","unstructured":"Gibson CJ, Lindsley RC, Tchekmedyian V, Mar BG, Shi J, Jaiswal S, et al. Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma. J Clin Oncol. 2017;35:1598\u2013605.","journal-title":"J Clin Oncol"},{"key":"2946_CR32","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41375-019-0633-3","volume":"34","author":"L Hartmann","year":"2020","unstructured":"Hartmann L, Nadarajah N, Meggendorfer M, H\u00f6llein A, Vetro C, Kern W, et al. Molecular characterization of a second myeloid neoplasm developing after treatment for acute myeloid leukemia. Leukemia. 2020;34:811\u201320.","journal-title":"Leukemia"},{"key":"2946_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/bjh.18129","volume":"198","author":"MT Voso","year":"2022","unstructured":"Voso MT, Pandzic T, Falconi G, Den\u010di\u0107-Fekete M, De Bellis E, Scarfo L, et al. Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy. Br J Haematol. 2022;198:103\u201313.","journal-title":"Br J Haematol"},{"key":"2946_CR34","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1200\/JCO.23.02547","volume":"42","author":"C Yan","year":"2024","unstructured":"Yan C, Richard MA, Gibson CJ, He J, Bosworth A, Crossman DK, et al. Clonal hematopoiesis and therapy-related myeloid neoplasms after autologous transplant for hodgkin lymphoma. J Clin Oncol. 2024;42:2415\u201324.","journal-title":"J Clin Oncol"},{"key":"2946_CR35","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1182\/blood-2011-11-394775","volume":"119","author":"HC Hasselbalch","year":"2012","unstructured":"Hasselbalch HC. Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer? Blood. 2012;119:3219\u201325.","journal-title":"Blood"},{"key":"2946_CR36","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1101\/gad.260174.115","volume":"29","author":"KD Rasmussen","year":"2015","unstructured":"Rasmussen KD, Jia G, Johansen JV, Pedersen MT, Rapin N, Bagger FO, et al. Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis. Genes Dev. 2015;29:910\u201322.","journal-title":"Genes Dev"},{"key":"2946_CR37","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/s41375-018-0368-6","volume":"33","author":"MA Loberg","year":"2019","unstructured":"Loberg MA, Bell RK, Goodwin LO, Eudy E, Miles LA, SanMiguel JM, et al. Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis. Leukemia. 2019;33:1635\u201349.","journal-title":"Leukemia"},{"key":"2946_CR38","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1074\/jbc.RA118.006795","volume":"294","author":"JE Sandoval","year":"2019","unstructured":"Sandoval JE, Huang YH, Muise A, Goodell MA, Reich NO. Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners. J Biol Chem. 2019;294:4898\u2013910.","journal-title":"J Biol Chem"},{"key":"2946_CR39","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41588-022-01121-z","volume":"54","author":"SP Kar","year":"2022","unstructured":"Kar SP, Quiros PM, Gu M, Jiang T, Mitchell J, Langdon R, et al. Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis. Nat Genet. 2022;54:1155\u201366.","journal-title":"Nat Genet"},{"key":"2946_CR40","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1056\/NEJMoa2413361","volume":"392","author":"O Pich","year":"2025","unstructured":"Pich O, Bernard E, Zagorulya M, Rowan A, Pospori C, Slama R, et al. Tumor-infiltrating clonal hematopoiesis. N Engl J Med. 2025;392:1594\u2013608.","journal-title":"N Engl J Med"},{"key":"2946_CR41","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrrheum.2017.23","volume":"13","author":"KL Winthrop","year":"2017","unstructured":"Winthrop KL. The emerging safety profile of JAK inhibitors in rheumatic disease. Nat Rev Rheumatol. 2017;13:234\u201343.","journal-title":"Nat Rev Rheumatol"},{"key":"2946_CR42","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3390\/cells8080854","volume":"8","author":"F Perner","year":"2019","unstructured":"Perner F, Perner C, Ernst T, Heidel FH. Roles of JAK2 in aging, inflammation, hematopoiesis and malignant transformation. Cells. 2019;8:854.","journal-title":"Cells"},{"key":"2946_CR43","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1182\/bloodadvances.2020004173","volume":"5","author":"CA Lachowiez","year":"2021","unstructured":"Lachowiez CA, Loghavi S, Furudate K, Montalban-Bravo G, Maiti A, Kadia T, et al. Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax. Blood Adv. 2021;5:2173\u201383.","journal-title":"Blood Adv"},{"key":"2946_CR44","unstructured":"Public Health England. Chemotherapy, radiotherapy and surgical tumour resections in England (Official statistics). GOV.UK:2020.https:\/\/www.gov.uk\/government\/statistics\/chemotherapy-radiotherapy-and-surgical-tumour-resections-in-england."}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02946-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02946-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02946-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:03:17Z","timestamp":1780470197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02946-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2946"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-02946-x","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"16 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}